--:--:--ET

live

S&P 5007,386.65+2432920.42%

NASDAQ29,084.5+1553750387.48%

DOW50,872.11+2.56%

VIX20.95+16.00%

US10Y4.53+1.21%

EUR/USD1.1535+0.05%

GOLD4,255.9-2.15%

WTI89.00+2217.71%

BTC27.44-99.96%

S&P 5007,386.65+2432920.42%

NASDAQ29,084.5+1553750387.48%

DOW50,872.11+2.56%

VIX20.95+16.00%

US10Y4.53+1.21%

EUR/USD1.1535+0.05%

GOLD4,255.9-2.15%

WTI89.00+2217.71%

BTC27.44-99.96%

LAURUSLABS.BO

Laurus Labs Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$1,422.15

Jun 09, 2026

Market cap

$781.07B

52w range

—

P / E

—

EPS · FY 2026

$16.45

Volume

—

Revenue · FY 2026

$68.13B

Overview Profile Financials Ratios Multiples Valuation Factors Quant Themes Trend Thesis Committee Earnings Segments Prices Analysts Dividends Corp actions Sentiment ESG

Explain this page

Arphra AIPlain-English read on Laurus Labs Limited’s valuation

Revenue · 5Y

$68.13B

FY26

Net income · 5Y

$8.89B

FY26

Margins · FY2026

Gross margin40.2%

Operating margin19.0%

Net margin13.0%

FCF margin5.7%

income_statement_annual

Line item	FY2026	YoY
Revenue	68.13B	—
Gross profit	27.42B	—
R&D	0	—
Operating income	12.98B	—
Net income	8.89B	—
Diluted EPS	16.45	—
Net margin	13.0%	—

Pro

Financials

Full income statement, balance sheet, and cash-flow history is included with Pro.